Xilis
PrivateLast Round
Series A
Extension
Jul 13, 2022
Total Funding Raised
$28.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Xilis is a biotechnology company that develops MicroOrganoSphere (MOS) technology to guide precision therapy for cancer patients and accelerate drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xilis Comparables
Compare Xilis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AimingMed | 83% | |
| Keliomics | 81% | |
| Shanghai Wanheyuan Biotechnology Co., Ltd. | 79% | |
Xilis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 13, 2022 | ||||
| Debt | Jul 8, 2021 | ||||
| Seed | May 21, 2020 | ||||
| Seed | Dec 19, 2019 |
Xilis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Debt, Series A Extension |
| GV | Debt, Series A Extension |
| The Duke Endowment | Debt |
| Alix Ventures | Debt, Series A Extension |
| Catalio Capital Management | Debt, Series A Extension |
| Two Sigma Ventures | Debt, Series A Extension |
| Pear VC | Series A Extension, Seed, Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 480% MoM to 2.2K.
Xilis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xilis's valuation, stock price, and market status.